1. Home
  2. Directory
  3. Mississippi
  4. Meridian
  5. Emergency Medicine
  6. NPI Profile
  7. Prescriptions 1043673833

DR. JAMES MARK SHOCKLEY M.D.
Prescription History 1043673833
Emergency Medicine in Meridian, MS


Quality Rating: 97.58 out of 100 score

NPI Status: Active since March 30, 2016

Contact Information

2124 14TH ST
MERIDIAN, MS
ZIP 39301
Phone: (601) 553-6000
Fax: (601) 553-6144

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JAMES MARK SHOCKLEY M.D., an active Emergency Medicine specialist practicing in Meridian, MS. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 52 documented patient claims. Among these therapy options, the most frequently utilized medication is Methocarbamol, which accounts for 15 claims alone.

Medication Index

C
M
P
No matching medications currently found on file.

Cefdinir

Generic Formulation: CefdinirSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 123
MS State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills33.7
Peer Average Days Supply297
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.6% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $336.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.91

State Avg Cost Per Claim

$21.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin.

Therapeutic Applications

Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 122
MS State Average Benchmarks
Peer Average Claims78.0
Peer Average 30-Day Fills135.5
Peer Average Days Supply3,966
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.6% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $29.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.48

State Avg Cost Per Claim

$6.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 114
MS State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills35.2
Peer Average Days Supply833
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $104.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.94

State Avg Cost Per Claim

$11.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Prednisone

Generic Formulation: PrednisoneSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 49
MS State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills61.6
Peer Average Days Supply1,095
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.5% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $19.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.62

State Avg Cost Per Claim

$5.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. JAMES MARK SHOCKLEY M.D. provides transparency into local medical care patterns within Meridian, MS.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Emergency Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.